Cleared Special

K160392 - Novilase Laser Therapy System

K160392 is an FDA 510(k) clearance for Novilase Laser Therapy System, manufactured by Novian Health, Inc.. The device is a Class 2 General & Plastic Surgery device with product code GEX cleared through the Special 510(k) pathway after a 15-day FDA review.

K160392 · Novian Health, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2016
Decision
15d
Days
Class 2
Risk

K160392 is an FDA 510(k) clearance for the Novilase Laser Therapy System, Model LTS-2. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Novian Health, Inc. (Chicago, US). The FDA issued a Cleared decision on February 26, 2016 after a review of 15 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Novian Health, Inc. devices

FDA 510(k) Submission Details - K160392

510(k) Number K160392 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 11, 2016
Decision Date February 26, 2016
Days to Decision 15 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
100d faster than avg
Panel avg: 115d · This submission: 15d
Pathway characteristics
Modification to existing cleared device.

GEX Device Classification - Class 2, Special Controls

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 1545
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K160392.
EVO platform
K160368 · Quanta System Spa · Apr 2016
Quanta System Surgical Laser fibers
K160513 · Quanta System Spa · Mar 2016
Family of CoolGlide Aesthetic Lasers
K153671 · Cutera, Inc. · Mar 2016
Quanta Forte
K152714 · Quanta System Spa · Dec 2015
MicroSpot Handpiece
K152153 · Asclepion Laser Technologies GmbH · Dec 2015
EVO platform
K152012 · Quanta System Spa · Dec 2015